Filter
241
Featured
Language
Document type
135
27
27
21
12
11
2
2
2
1
1
Countries
7
6
6
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
51
27
18
10
10
7
7
5
5
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
31
21
8
4
4
2
1
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux Deuxième édition - Juin 2018
End TB. Accessed in November 2017.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis. Accessed in November 2017.
A review of available evidence (2016). 28-29 June 2016; Geneva, Switzerland The END TB strategy.
Report: A survey conducted among the 27 high MDR-TB burden countries. March – July 2015 Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF). Accessed November 2017.
Public Health Fact Sheet Involving the Community in Responding to TB/HIV: Outcomes of Community-Led Monitoring and Advocacy Accessed November 2017
Global Plan to end TB 2016-2020
Accessed November 2017
Accessed November 2017
TB policies in 29 Countries A survey of prevention, testing and treatment policies and practices
Technical Brief
END TB Second Meeting of th WHO Global Coordination Mechanism (GCM/NCD) Working Group on the inclusion of NCDs in other programmatic areas. Accessded December 2017
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Eur Respir J 2017; 50: 1700918
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Clinical Medicine JCI Insight. 2017;2(7):e91963.
Accessed December 2017